美股异动 | 安进(AMGN.US)涨6% 三季度销售额超预期并上调全年业绩指引

Core Viewpoint - Amgen (AMGN.US) reported a strong performance in Q3, with sales and earnings exceeding analyst expectations, leading to an upward revision of its full-year guidance [1] Financial Performance - Q3 sales increased by 12% year-over-year to $9.56 billion, surpassing analyst expectations of $8.97 billion [1] - Adjusted earnings per share (EPS) were $5.64, exceeding the forecast of $5.01 [1] Guidance Update - The company raised its full-year sales guidance to a range of $35.8 billion to $36.6 billion [1] - Full-year EPS is now expected to be between $20.6 and $21.4 [1]